Medical Journals In Microrna Profiling

Clinical Journals give a stage to exceptional examination around the world in the field of medication. These insightful diaries intend to add to the advancement and utilization of logical disclosures, by giving free access to the examination data. The distributed work arrives at the overall population and established researchers following distribution, in this manner giving higher reference rates to the creator. Clinical Journals are bolstered by 5000 universally eminent article board individuals and a top notch survey board. Clinical Journals utilize online Editorial Manager System for snappy and top notch survey process. Articles of Medical diaries are exposed to peer investigating and these are remembered for the standard ordering databases like ISI, Scopus, EBSCO, CAS, HINARI and so on.

High Impact List of Articles

Soy isoflavones (Glycine max) attenuates bilateral ovariectomy (experimental menopause) induced alteration in the hepatic and renal metabolic functions in female Wistar rats Sankar P, Rajaa Muthu P, Bobby Z and Sridhar MG
Research Article: Clinical Investigation
Soy isoflavones (Glycine max) attenuates bilateral ovariectomy (experimental menopause) induced alteration in the hepatic and renal metabolic functions in female Wistar rats Sankar P, Rajaa Muthu P, Bobby Z and Sridhar MG
Research Article: Clinical Investigation
Soy isoflavones (Glycine max) attenuates bilateral ovariectomy (experimental menopause) induced alteration in the hepatic and renal metabolic functions in female Wistar rats Sankar P, Rajaa Muthu P, Bobby Z and Sridhar MG
Research Article: Clinical Investigation
Soy isoflavones (Glycine max) attenuates bilateral ovariectomy (experimental menopause) induced alteration in the hepatic and renal metabolic functions in female Wistar rats Sankar P, Rajaa Muthu P, Bobby Z and Sridhar MG
Research Article: Clinical Investigation
Soy isoflavones (Glycine max) attenuates bilateral ovariectomy (experimental menopause) induced alteration in the hepatic and renal metabolic functions in female Wistar rats Sankar P, Rajaa Muthu P, Bobby Z and Sridhar MG
Research Article: Clinical Investigation
Soy isoflavones (Glycine max) attenuates bilateral ovariectomy (experimental menopause) induced alteration in the hepatic and renal metabolic functions in female Wistar rats Sankar P, Rajaa Muthu P, Bobby Z and Sridhar MG
Research Article: Clinical Investigation
Soy isoflavones (Glycine max) attenuates bilateral ovariectomy (experimental menopause) induced alteration in the hepatic and renal metabolic functions in female Wistar rats Sankar P, Rajaa Muthu P, Bobby Z and Sridhar MG
Research Article: Clinical Investigation
Soy isoflavones (Glycine max) attenuates bilateral ovariectomy (experimental menopause) induced alteration in the hepatic and renal metabolic functions in female Wistar rats Sankar P, Rajaa Muthu P, Bobby Z and Sridhar MG
Research Article: Clinical Investigation
Sex, gender and clinical research: have you considered the possibilities? Joy Johnson
Editorial: Clinical Investigation
Sex, gender and clinical research: have you considered the possibilities? Joy Johnson
Editorial: Clinical Investigation
Sex, gender and clinical research: have you considered the possibilities? Joy Johnson
Editorial: Clinical Investigation
Sex, gender and clinical research: have you considered the possibilities? Joy Johnson
Editorial: Clinical Investigation
Sex, gender and clinical research: have you considered the possibilities? Joy Johnson
Editorial: Clinical Investigation
Sex, gender and clinical research: have you considered the possibilities? Joy Johnson
Editorial: Clinical Investigation
Sex, gender and clinical research: have you considered the possibilities? Joy Johnson
Editorial: Clinical Investigation
Sex, gender and clinical research: have you considered the possibilities? Joy Johnson
Editorial: Clinical Investigation
The UK Dermatology Clinical Trials Network: how far have we come? Carron Layfield, Adrian Yong, Kim Thomas and Hywel Williams
Research Update: Clinical Investigation
The UK Dermatology Clinical Trials Network: how far have we come? Carron Layfield, Adrian Yong, Kim Thomas and Hywel Williams
Research Update: Clinical Investigation
The UK Dermatology Clinical Trials Network: how far have we come? Carron Layfield, Adrian Yong, Kim Thomas and Hywel Williams
Research Update: Clinical Investigation
The UK Dermatology Clinical Trials Network: how far have we come? Carron Layfield, Adrian Yong, Kim Thomas and Hywel Williams
Research Update: Clinical Investigation
The UK Dermatology Clinical Trials Network: how far have we come? Carron Layfield, Adrian Yong, Kim Thomas and Hywel Williams
Research Update: Clinical Investigation
The UK Dermatology Clinical Trials Network: how far have we come? Carron Layfield, Adrian Yong, Kim Thomas and Hywel Williams
Research Update: Clinical Investigation
The UK Dermatology Clinical Trials Network: how far have we come? Carron Layfield, Adrian Yong, Kim Thomas and Hywel Williams
Research Update: Clinical Investigation
The UK Dermatology Clinical Trials Network: how far have we come? Carron Layfield, Adrian Yong, Kim Thomas and Hywel Williams
Research Update: Clinical Investigation
Parkinsons disease: will therapy move beyond dopaminergic medication? Livia Dezsi,L Vecsei
Review Article: Clinical Investigation
Parkinsons disease: will therapy move beyond dopaminergic medication? Livia Dezsi,L Vecsei
Review Article: Clinical Investigation
Parkinsons disease: will therapy move beyond dopaminergic medication? Livia Dezsi,L Vecsei
Review Article: Clinical Investigation
Parkinsons disease: will therapy move beyond dopaminergic medication? Livia Dezsi,L Vecsei
Review Article: Clinical Investigation
Parkinsons disease: will therapy move beyond dopaminergic medication? Livia Dezsi,L Vecsei
Review Article: Clinical Investigation
Parkinsons disease: will therapy move beyond dopaminergic medication? Livia Dezsi,L Vecsei
Review Article: Clinical Investigation
Parkinsons disease: will therapy move beyond dopaminergic medication? Livia Dezsi,L Vecsei
Review Article: Clinical Investigation
Parkinsons disease: will therapy move beyond dopaminergic medication? Livia Dezsi,L Vecsei
Review Article: Clinical Investigation
Velaglucerase alfa in the treatment of Gaucher disease type 1 Thomas A Burrow, Gregory A Grabowski
Review Article: Clinical Investigation
Velaglucerase alfa in the treatment of Gaucher disease type 1 Thomas A Burrow, Gregory A Grabowski
Review Article: Clinical Investigation
Velaglucerase alfa in the treatment of Gaucher disease type 1 Thomas A Burrow, Gregory A Grabowski
Review Article: Clinical Investigation
Velaglucerase alfa in the treatment of Gaucher disease type 1 Thomas A Burrow, Gregory A Grabowski
Review Article: Clinical Investigation
Velaglucerase alfa in the treatment of Gaucher disease type 1 Thomas A Burrow, Gregory A Grabowski
Review Article: Clinical Investigation
Velaglucerase alfa in the treatment of Gaucher disease type 1 Thomas A Burrow, Gregory A Grabowski
Review Article: Clinical Investigation
Velaglucerase alfa in the treatment of Gaucher disease type 1 Thomas A Burrow, Gregory A Grabowski
Review Article: Clinical Investigation
Velaglucerase alfa in the treatment of Gaucher disease type 1 Thomas A Burrow, Gregory A Grabowski
Review Article: Clinical Investigation

Clinical Investigation

Medical Journals In Microrna Profiling

High Impact List of Articles

Relevant Topics in Clinical